SN
Shravan Narsingrao Tungenwar
About Shravan Narsingrao Tungenwar
Data last updated:
Shravan Narsingrao Tungenwar is an Additional Director at Crete Pharma Private Limited (since 2021) and Designated Partner at Niryom Onco Care Llp (since 2021). The companies operate in Pharma and Healthcare. The largest current company by reported revenue is Crete Pharma Private Limited at ₹74.7 Lakh (FY 2021). Earlier, Shravan Narsingrao Tungenwar was a Director at Austin Oncology Solutions Private Limited (2018–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Crete Pharma Private Limited U24233MH2015PTC268969 | Additional Director | 08 Jun 2021 | 2015 | ₹74.7 Lakh (FY 2021) | Active |
| Niryom Onco Care Llp AAN-8538 | Designated Partner | 04 Mar 2021 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Austin Oncology Solutions Private Limited U74999MH2018PTC311835 | Director | 12 Jul 2018 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shravan Narsingrao Tungenwar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arunesh Balkashanmugam | 02985483 | Crete Pharma Private Limited | Director |
| Surendra Balasaheb Bhalekar | 03021434 | Crete Pharma Private Limited | Director |
| Hemchand Chainrupchand Bhandari | 09424652 | Niryom Onco Care Llp | Designated Partner |
| Hrushikesh Pralhad Chaudhari | 09091837 | Niryom Onco Care Llp | Designated Partner |
| Nitin Laxman Chaudhari | 08314941 | Niryom Onco Care Llp | Designated Partner |
| Yogesh Pralhad Chaudhari | 08243542 | Niryom Onco Care Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shravan Narsingrao Tungenwar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shravan Narsingrao Tungenwar
Shravan Narsingrao Tungenwar currently holds 2 directorships: Crete Pharma Private Limited (Additional Director, since 08 Jun 2021, revenue ₹74.7 Lakh (FY 2021)); Niryom Onco Care Llp (Designated Partner, since 04 Mar 2021).
Shravan Narsingrao Tungenwar was first appointed on 12 Jul 2018 as Director at Austin Oncology Solutions Private Limited. The most recent appointment on record is 08 Jun 2021 at Crete Pharma Private Limited.
Shravan Narsingrao Tungenwar held 1 earlier board appointment: Austin Oncology Solutions Private Limited (Director, 12 Jul 2018 to 14 Mar 2023).
The current boards of Shravan Narsingrao Tungenwar's companies include Arunesh Balkashanmugam (Crete Pharma Private Limited), Surendra Balasaheb Bhalekar (Crete Pharma Private Limited), Hemchand Chainrupchand Bhandari (Niryom Onco Care Llp), Hrushikesh Pralhad Chaudhari (Niryom Onco Care Llp), Nitin Laxman Chaudhari (Niryom Onco Care Llp), Yogesh Pralhad Chaudhari (Niryom Onco Care Llp).